Production (Stage)
Bicara Therapeutics Inc.
BCAX
$9.27
-$6.39-40.81%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/25/2025
-
MarketBeat
5/25/2025
-
MarketBeat
5/24/2025
-
Ticker Report
5/23/2025
-
Benzinga
5/23/2025
-
GuruFocus
5/23/2025
-
GuruFocus
5/23/2025
-
GuruFocus
5/23/2025
-
TipRanks Financial Blog
5/23/2025
-
TipRanks Financial Blog
5/23/2025
-
The Fly
5/23/2025
-
GuruFocus
5/22/2025
-
GuruFocus
5/22/2025
-
The Fly
5/22/2025
-
GuruFocus
5/22/2025
-
GuruFocus
5/22/2025
-
Globe Newswire
5/22/2025
-
MarketBeat
5/21/2025
-
MarketBeat
5/16/2025
-
GuruFocus
5/16/2025
-
The Fly
5/16/2025
-
MarketBeat
5/15/2025
-
MarketBeat
Bicara Therapeutics (NASDAQ:BCAX) Releases Quarterly Earnings Results, Misses Estimates By $0.28 EPS
5/15/2025
-
MarketBeat
5/15/2025
-
MarketBeat
5/15/2025
-
GuruFocus
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
--
EBIT (TTM)
--
Net Income (TTM)
--
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
--
Cash from Investing (TTM)
--
Cash from Financing (TTM)
--
Net Change in Cash (TTM)
--
Filings
Filing Date
Tuesday, May 13, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 18 and 22 (est)
Price History
Beta
--
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
--
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
617 468 4219
Address
116 Huntington Avenue
Boston, MA 02116
Boston, MA 02116
Country
Year Founded
Business Description
Sector
Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in the development of bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional...
more